Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2024-12-18 00:00:00 ET · period of report 2024-12-16 · accession 0001601830-24-000247 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-12-18 | 2024-12-16+ | RXRX | Taylor Ben R | CFO | F - Tax | $6.32 | -22.7K | 480.9K | -5% | -$143.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-12-17 | F | D | 7,057 | $6.95 | 473,867 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-12-16 | F | D | 15,668 | $6.04 | 480,924 | D | — | — |